000			03240nam a22004095i 4500
001			85007
003			ES-MaUEC
005			20230221040152.0
007			cr nn 008mamaa
008			151214s2016 gw | s |||| 0|eng d
020			_a9783319242231
040			_aES-MaUEC
050		4	_aRC280.L8 _bL864 2016
082	0	4	_a614.5999
245	1	0	_aLung Cancer and Personalized Medicine : _bCurrent Knowledge and Therapies _cedited by Aamir Ahmad, Shirish Gadgeel
250			_a1st ed.
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XIII, 228 páginas) _b26 ilustraciones, 14 ilustraciones en color
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	0		_aAdvances in Experimental Medicine and Biology _x0065-2598 _v893
505	0		_a1 Lung Cancer Statistics -- 2 Epidemiology of Lung Cancer -- 3 Lung Cancer In Never Smokers -- 4 Immune Therapy -- 5 Anti-angiogenesis in personalized therapy of lung cancer -- 6 Target therapy in Lung Cancer -- 7 Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors and Therapeutic Approaches: an update -- 8 KRAS-Mutant Lung Cancers in the Era of Targeted Therapy -- 9 Anaplastic Lymphoma Kinase (ALK) Signaling in Lung Cancer -- 10 Chemotherapy Resistance in Lung Cancer -- 11 Current state of metal-based drugs for the efficient therapy of lung cancers and lung metastases.
520	3		_aThis, the first of two volumes on personalized medicine in lung cancer, touches on the core issues related to the understanding of lung cancer�statistics and epidemiology of lung cancer�along with the incidence of lung cancer in non-smokers. A major focus of this volume is the state of current therapies against lung cancer�immune, targeted therapies against EGFR TKIs, KRAS, ALK, angiogenesis; the associated challenges, especially resistance mechanisms; and recent progress in targeted drug development based on metal chemistry. Chapters are written by some of the leading experts in the field, who provide a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans. With a unique mix of topics, this volume summarizes the current state-of-knowledge on lung cancer and the available therapies.
710	2		_aSpringerLink (Online service) _0Local _9106996
942			_2lcc _cLE
988			_aEBOOK, asignarmaterias , EBSPRINGER
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_aCáncer _xInvestigación _0comprobar BNE19901364217 _2embne _9182523
700	1		_aAhmad, Aamir _eeditor literario _0Local _984636
700			_aGadgeel, Shirish M. _eeditor literario _0Local _997740
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-24223-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319242231
907			_a.b12942856 _b10-10-17 _c21-11-16
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0
945			_aRC280.L8 L864 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11587131 _z06-04-17
999			_c85007 _d85007 _x1